Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer

Cancer drug resistance has always been a major factor affecting the treatment of non-small cell lung cancer, which reduces the quality of life of patients. The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) technology, as an efficient and convenie...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lu, Liao, Zhi, Liu, Zhixi, Chen, Yan, Huang, Tingwenli, Xiao, Hongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127258/
https://www.ncbi.nlm.nih.gov/pubmed/35620280
http://dx.doi.org/10.3389/fphar.2022.900825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127258/
https://www.ncbi.nlm.nih.gov/pubmed/35620280
http://dx.doi.org/10.3389/fphar.2022.900825

Ejemplares similares